BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 2575061)

  • 1. Treatment of reflux oesophagitis resistant to H2-receptor antagonists.
    Klinkenberg-Knol EC; Meuwissen SG
    Digestion; 1989; 44 Suppl 1():47-53. PubMed ID: 2575061
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of omeprazole in the management of reflux oesophagitis resistant to H2-receptor antagonists.
    Klinkenberg-Knol EC; Jansen JB; Lamers CB; Nelis F; Snel P; Meuwissen SG
    Scand J Gastroenterol Suppl; 1989; 166():88-93; discussion 94. PubMed ID: 2574911
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of omeprazole in healing and prevention of reflux disease.
    Klinkenberg-Knol EC
    Hepatogastroenterology; 1992 Feb; 39 Suppl 1():27-30. PubMed ID: 1577392
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Histamine H2 receptor antagonist-refractory oesophagitis: the efficacy of long-term omeprazole maintenance treatment.
    Bardhan KD; Cherian P; Jones RB; Vaishnavi A; Manek S; Bishop A; Polak J; Brooks A; Morris P; Thompson M; D'Silva J; Parkin S; Patterson J; Gillon KR
    Ital J Gastroenterol Hepatol; 1997 Dec; 29(6):515-9. PubMed ID: 9513825
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Medical therapy of patients with reflux oesophagitis poorly responsive to H2-receptor antagonist therapy.
    Klinkenberg-Knol EC; Meuwissen SG
    Digestion; 1992; 51 Suppl 1():44-8. PubMed ID: 1356868
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prospective evaluation of omeprazole treatment in reflux oesophagitis refractory to H2-receptor antagonists.
    Koop H; Hotz J; Pommer G; Klein M; Arnold R
    Aliment Pharmacol Ther; 1990 Dec; 4(6):593-9. PubMed ID: 1983342
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Omeprazole. An updated review of its pharmacology and therapeutic use in acid-related disorders.
    McTavish D; Buckley MM; Heel RC
    Drugs; 1991 Jul; 42(1):138-70. PubMed ID: 1718683
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Omeprazole in H2 receptor antagonist-resistant reflux esophagitis.
    Marciano-D'Amore DA; Paterson WG; Da Costa LR; Beck IT
    J Clin Gastroenterol; 1990 Dec; 12(6):616-20. PubMed ID: 1979984
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Omeprazole in the short-term treatment of reflux oesophagitis.
    Jansen JB; Lamers CB
    Digestion; 1989; 44 Suppl 1():40-6. PubMed ID: 2691310
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Experience with omeprazole in erosive oesophagitis.
    Robinson MG; Decktor DL
    Aliment Pharmacol Ther; 1991; 5 Suppl 1():69-77. PubMed ID: 1679674
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of reflux oesophagitis with H2-receptor antagonists.
    Meuwissen SG; Klinkenberg-Knol EC
    Scand J Gastroenterol Suppl; 1988; 146():201-13. PubMed ID: 2906465
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lansoprazole heals erosive reflux esophagitis resistant to histamine H2-receptor antagonist therapy.
    Sontag SJ; Kogut DG; Fleischmann R; Campbell DR; Richter J; Robinson M; McFarland M; Sabesin S; Lehman GA; Castell D
    Am J Gastroenterol; 1997 Mar; 92(3):429-37. PubMed ID: 9068463
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Conservative treatment of florid peptic esophageal stenosis. Complete elimination by dilatation and omeprazole in H2-blocker refractory cases].
    Koop H; Katschinski M; Arnold R
    Med Klin (Munich); 1991 Nov; 86(11):566-8. PubMed ID: 1685214
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Omeprazole versus high-dose ranitidine in mild gastroesophageal reflux disease: short- and long-term treatment. The Dutch Reflux Study Group.
    Festen HP; Schenk E; Tan G; Snel P; Nelis F
    Am J Gastroenterol; 1999 Apr; 94(4):931-6. PubMed ID: 10201459
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical development programme for omeprazole.
    Walan A
    Digestion; 1990; 47 Suppl 1():54-8; discussion 76. PubMed ID: 2093016
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The use of omeprazole for resistant oesophagitis in children.
    Martin PB; Imong SM; Krischer J; Noblett HR; Sandhu BK
    Eur J Pediatr Surg; 1996 Aug; 6(4):195-7. PubMed ID: 8877348
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is there a need for strong gastric acid inhibition in clinical practice?
    Lamers CB
    Digestion; 1989; 44 Suppl 1():4-8. PubMed ID: 2691309
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Temporary cessation of long-term maintenance treatment with omeprazole in patients with H2-receptor-antagonist-resistant reflux oesophagitis. Effects on symptoms, endoscopy, serum gastrin, and gastric acid output.
    Klinkenberg-Knol EC; Jansen JB; Lamers CB; Nelis F; Meuwissen SG
    Scand J Gastroenterol; 1990 Nov; 25(11):1144-50. PubMed ID: 1980377
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Management of gastro-oesophageal reflux disease. Are there alternatives to omeprazole?
    Meuwissen SG; Klinkenberg-Knol EC
    Digestion; 1989; 44 Suppl 1():54-62. PubMed ID: 2575062
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Omeprazole in the treatment of patients with complicated gastro-oesophageal reflux disease.
    Jaspersen D; Schwacha H; Schorr W; Brennenstuhl M; Raschka C; Hammar CH
    J Gastroenterol Hepatol; 1996 Oct; 11(10):900-2. PubMed ID: 8912123
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.